Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effects of VX-407 on the Pharmacokinetics of Combined Oral Contraceptives
Sponsor: Vertex Pharmaceuticals Incorporated
Summary
The purpose of the study is to evaluate the pharmacokinetic effects and safety and tolerability of VX-407 when coadministered with oral contraceptives.
Official title: A Phase 1, Open-label Drug Interaction Study to Evaluate the Effect of VX-407 on the Pharmacokinetics of Combined Oral Contraceptives
Key Details
Gender
FEMALE
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
148
Start Date
2026-08-28
Completion Date
2027-03-20
Last Updated
2026-08-28
Healthy Volunteers
Yes
Interventions
VX-407
Tablets for Oral Administration.
LNG/EE
Combination Tablets for Oral Administration.
NGM/EE
Combination Tablets for Oral Administration.
NET/EE
Combination Tablets for Oral Administration.
DRSP/EE
Combination Tablets for Oral Administration.